Akanda Corporation Announces Completion of F-3 Shelf Registration Statement

Core Points - Akanda Corporation has completed sales of its securities under an existing Form F-3 shelf registration, raising approximately $4.98 million in gross proceeds since its effectiveness on January 29, 2024 [2][3]. - The company has maxed out its $5 million capacity under the F-3 shelf registration and will not raise further funds under this statement, indicating future offerings will require a new registration statement [3]. Company Overview - Akanda is an international medical cannabis and wellness platform focused on improving access to high-quality and affordable products [4]. - The company's portfolio includes CanMart, a UK-based licensed pharmaceutical importer and distributor, and partnerships with Cellen Life Sciences' Leva Clinic, a digital pain clinic in the UK [4]. - Akanda has acquired rights to develop a farming property in British Columbia for THC and cannabinoid (CBD) facilities [4].